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Abstract
Among protein secretion systems there are specialized ATPases that serve different functions such 
as substrate recognition, substrate unfolding, and assembly of the secretory machinery. ESX 
protein secretion systems require FtsK/SpoIIIE family ATPases but the specific function of these 
ATPases is poorly understood. The ATPases of ESX secretion systems have a unique domain 
architecture among proteins of the FtsK/SpoIIIE family. All well-studied FtsK family ATPases to 
date have one ATPase domain and oligomerize to form a functional molecular machine, most 
commonly a hexameric ring. In contrast, the ESX ATPases have three ATPase domains, either 
encoded by a single gene or by two operonic genes. It is currently unknown which of the ATPase 
domains is catalytically functional and whether each domain plays the same or a different 
function. Here we focus on the ATPases of two ESX systems, the ESX-1 system of 
Mycobacterium tuberculosis and the yuk system of Bacillus subtilis. We show that ATP hydrolysis 
by the ESX ATPase is required for secretion, suggesting that this enzyme at least partly fuels 
protein translocation. We further show that individual ATPase domains play distinct roles in 
substrate translocation and complex formation. Comparing the single chain and split ESX 
ATPases we reveal differences in the requirements of these unique secretory ATPases.
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The majority of protein export systems contain associated ATPases that supply energy for 
functions including assembly of the secretory apparatus and substrate translocation. FtsK/
SpoIIIE family ATPases are conserved throughout bacteria and are involved in the 
translocation of DNA and proteins through membrane-spanning pores [1]. This translocation 
is important for cell division, sporulation, DNA conjugation, and other essential cell 
processes. FtsK/SpoIIIE family proteins are members of the larger FtsK-HerA superfamily 
of P-loop ATPases [1]. This superfamily includes VirB4-like ATPases of Type IV secretion 
systems, TrwB-like proteins involved in conjugal transfer of plasmids, and HerA family 
archeal helicases.
FtsK-HerA superfamily proteins share a characteristic molecular organization consisting of 
several N-terminal transmembrane segments followed by a cytoplasmic domain containing a 
single ATP-binding motif [2]. Because of the conservation and biological importance of 
these ATPases, numerous studies have investigated the structure and oligomeric state of 
these proteins. Structural analyses of FtsK, TwrB, and HerA have revealed that these 
proteins have a strong preference for forming ring-shaped hexamers [3-5], a preference 
extending throughout prokaryotic and eukaryotic organisms. For example, the single 
cytoplasmic ATPase domain from six FtsK monomers assemble into a homohexameric ring 
to create a pore with a central channel large enough to allow the passage of the double 
stranded DNA substrate [5]. The hexameric architecture of FtsK-HerA ATPases is a shared 
feature among many members of the larger AAA+ (ATPases Associated with various 
cellular Activities) and RecA protein families [6-8].
Recent work has revealed the presence of FtsK/SpoIIIE family ATPases in ESX secretion 
systems [9, 10]. ESX secretion systems (also referred to as Wss for WXG100 secretion 
system or Type VII in some instances) are a novel class of bacterial secretion systems 
[10-13]. The first identified ESX system was the ESX-1 secretion system of the human 
pathogen Mycobacterium tuberculosis [9, 14-16], and it has been shown that ESX-1 is a 
critical mediator of M. tuberculosis virulence [17, 18]. Subsequent genome sequence 
analyses have demonstrated a wide distribution of ESX systems throughout actinobacteria, 
firmicutes, chloroflexi, and several proteobacteria [9, 11, 16]. Within genetic loci encoding 
for ESX systems, two proteins are conserved among all species: an ATPase with multiple 
FtsK/SpoIIIE-like domains and a small substrate protein homologous to the secreted 
virulence factor EsxA of M. tuberculosis [9]. The molecular function and mechanisms of 
action of these systems remain poorly understood.
There are several unique structural features of the secretory FtsK-like ESX ATPases. First, 
whereas canonical members of the FtsK/SpoIIIE protein family contain a single enzymatic 
domain, the FtsK/SpoIIIE family ATPases of ESX secretion systems are predicted to contain 
two or three ATPase domains linked within a single polypeptide [9, 10]. Another striking 
feature of these FtsK/SpoIIIE family ATPases is the architecture of the genes encoding these 
proteins. In most ESX systems, the multidomain ATPase is encoded for by a single gene. 
For example, the gene yukBA of the Bacillus subtilis yuk secretion system encodes one 
protein with three predicted ATPase domains (Fig. 1a). However, an alternative protein 
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architecture is found in some ESX systems. For example, in the ESX-1 system of M. 
tuberculosis, the open reading frame encoding the ATPase has been split into two genes, 
eccCa and eccCb, containing one and two ATPase domains respectively (Fig. 1a) [16].
As suggested by the conservation of FtsK/SpoIIIE family ATPases among ESX systems, 
these ATPases are integral components of these secretion systems. Studies of ESX secretion 
systems from multiple organisms have demonstrated that these ATPases are required for 
substrate secretion [17, 19-22]. In mycobacteria both proteins in the split ESX ATPase, 
EccCa and EccCb, are required for secretion but only the EccCb ATPase interacts with the 
EsxB substrate [23]. In Staphylococcus aureus there is a linked ESX ATPase EssC in which 
the second and the third domains are dispensable for secretion [19]. Therefore, it is unclear 
whether each of the ATPase domains within these proteins is required for function, and if so, 
whether the multiple active sites contribute equally to function. Moreover, it is unknown 
how the split protein architecture of these ATPases reflects or affects protein function and 
assembly.
In this work, we address these questions by studying the ATPases of ESX systems 
representing two different ATPase protein architectures – single-chain and split protein 
variants. First, we make use of the model system that we have developed using the yuk 
secretion system of B. subtilis and analyze the single-chain ESX ATPase YukBA [22, 24]. 
We show that there are different functional requirements for the three ATPase domains of 
YukBA, where catalytic activity of only the most N-terminal ATPase domain is required for 
secretion. The nucleotide binding and enzymatic function of the other two ATPase domains 
are not required for substrate secretion. In contrast, in the split ESX ATPase in M. 
tuberculosis, nucleotide binding by each of the three ATPase domains is required for protein 
secretion. Together, our data suggest that the FtsK/SpoIIIE family ATPases of ESX 
secretion systems supply energy for protein translocation via ATP hydrolysis by the most N-
terminal ATPase domain. Nucleotide binding by the second and third ATPase domains may 
be required for assembly or oligomerization of the functional apparatus, a requirement that 
becomes essential for ESX ATPases demonstrating a split protein architecture. This 
requirement may be alleviated in ESX systems in which the ATPase is a single polypeptide 
chain containing three linked ATPase domains.
Results
The ATPase domains of YukBA are differentially required for YukE secretion in B. subtilis
In the B. subtilis ESX secretion system, the FtsK/SpoIIIE family ATPase YukBA is required 
for the secretion of the EsxA homologue YukE [21, 22] (Fig. 2a). The Walker A motif 
(GXXXXGKT/S) is the conserved nucleotide binding site of P-loop NTPase domains [25, 
26]. YukBA contains three ATPase domains, each containing a Walker A motif with a 
conserved lysine (K) residue at amino acids K688, K1016, and K1299 (Fig. 1b). We sought 
to determine the requirement for each of the ATPase domains within YukBA in yuk-
mediated secretion. We inactivated each ATPase domain of YukBA by mutagenizing the 
conserved lysine residues to an alanine (A), both individually and in combination. This 
mutation prevents ATP binding in other systems, thereby disrupting the enzymatic activity 
of the ATPase domain [27, 28].
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We tested the ability of each ATPase mutant protein to complement the B. subtilis ΔyukBA 
strain for YukE secretion. As seen in Fig. 2, the ΔyukBA deletion strain failed to secrete 
YukE while introduction of a wild-type copy of yukBA into ΔyukBA partially restored YukE 
secretion. Mutating the most N-terminal ATPase domain of YukBAK688A, completely 
abolished YukE secretion (Fig. 2a). Moreover, any YukBA mutant containing the K688A 
mutation (YukBAK688A,K1016A, YukBAK688A,K1299A, or YukBAK688A,K1016A,K1299A) 
failed to complement ΔyukBA for secretion. This indicates that the first ATPase domain is 
fully required for YukE secretion.
In contrast, production of YukBA proteins with mutations of the catalytic lysines in the 
second or third ATPase domains, YukBAK1016A or YukBAK1299A, complemented YukE 
secretion in the ΔyukBA strain (Fig. 2a). Likewise, production of YukBAK1016A,K1299A 
restore YukE secretion to wild-type levels. Thus, neither YukBAK1016 nor YukBAK1299 are 
required for YukE secretion, individually or in combination.
To provide supporting evidence that the phenotypic consequence of the YukBA Walker A 
motif lysine to alanine mutations are specific to the loss of ATPase activity, as opposed to a 
less specific effect such as a global perturbation in enzyme structure, we also mutated each 
active site lysine of yukBA to a threonine (T). This amino acid substitution is also commonly 
used to eliminate the enzymatic activity of an ATPase [29, 30]. Consistent with our previous 
results, we found that mutating the most N-terminal ATPase domain of YukBA, 
YukBAK688T, resulted in a loss of YukE secretion (Fig. 2b). The YukBAK1016T, 
YukBAK1299T, and YukBAK1016T,K1299T mutant proteins were able to complement YukE 
secretion, as was seen with the corresponding lysine to alanine mutations. We also tested 
that all of the mutant YukBA proteins are produced in the cells to ensure that observed 
secretion changes are not due to protein stability or expression alterations (Fig. 2). In 
summary, we show that the three ATPase domains of YukBA are not functionally 
equivalent.
Walker A mutants of YukBA interfere with the functionality of the wild-type ATPase
The most N-terminal ATPase domain of YukBA is required for YukE secretion. We next 
assessed whether the YukBA ATPase mutant proteins have a dominant negative phenotype 
when expressed in the presence of a wild-type copy of the protein. Upon expression of 
yukBAK688A in an otherwise wild-type strain, we found a greater than 80% reduction in 
YukE secretion (Fig. 3a). Likewise, when the K688A mutation is combined with the 
mutation of either other Walker A motif (yukBAK688A,K1016A, yukBAK688A,K1299A, or 
yukBAK688A,K1016A,K1299A), we saw dramatically reduced YukE secretion as compared to a 
strain in which wild-type YukBA was heterologously expressed. In agreement with these 
findings, we found similar inhibition of secretion when K688 was mutated to a threonine, 
either individually or in combination with other Walker box mutations (Fig. 3b). Thus, a 
YukBA mutant protein that has been mutated at the first Walker A motif (YukBAK688) 
appears to retain some ability to interact with and subsequently inhibit wild-type 
components of the translocon.
We then assessed the effects of expressing yukBAK1016A or yukBAK1299A in the presence of a 
wild-type secretion system. Although neither Walker A motif was required for secretion 
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individually or in combination, both mutants had a minor effect on YukE secretion when 
lysines were substituted to alanines or threonines (Fig. 3a-b). Overall, experiments 
expressing mutant copies of the YukBA ATPase in the presence of the wild-type protein 
showed that the mutant protein can interfere with functioning of the wild-type ATPase, 
likely indicating that the proteins oligomerize.
ATP hydrolysis by the first ATPase domain of YukBA is required for secretion
Disruption of the Walker A residues by mutation commonly eliminates binding of 
nucleotides to the active site of the target P-loop ATPase, which subsequently renders 
nucleotide hydrolysis impossible. The Walker B motif, another consensus sequence found in 
ATPases (hhhhDE), is responsible for nucleotide hydrolysis [25, 26, 31]. To separate the 
effects of nucleotide binding and hydrolysis we introduced mutations in the Walker B motifs 
of two of the ATPase domains in YukBA, where we could identify such motifs (Fig. 1b). As 
one can see from Fig. 1a, the second and third ATPase domains of YukBA do not have the 
glutamate (E) following the conserved aspartate (D). In case of the second domain there is a 
nearby DE pair following the aligned hhhhDN. Therefore, to test the effect of eliminating 
ATP hydrolysis on the yuk secretion, we mutated to alanine Walker B residue D794 in the 
first domain and the two putative Walker B residues in the second domain, D1114 and 
D1121.
Using a similar secretion assay, we assessed YukE secretion upon ectopic expression of the 
YukBA Walker B mutants in the ΔyukBA strain. We found that the Walker B motif mutants 
showed similar phenotypes to those observed when we mutated the Walker A motif in each 
ATPase domain (Fig. 4a). YukBAD749A, the Walker B mutant of the most N-terminal 
ATPase domain, failed to restore secretion in the absence of the wild-type ATPase. In 
contrast, mutating either of the two putative Walker B domains of the second ATPase 
domain (residues D1114 and D1121) did not affect YukE secretion. This is consistent with 
our results that nucleotide binding to these domains is not required for secretion. Therefore, 
ATP hydrolysis by the first ATPase domain of YukBA is critical for secretory function. We 
further tested the effect of expressing each Walker B mutant in the context of the wild-type 
protein and observed that the Walker B mutation in the most N-terminal ATPase domain 
exhibited a dominant negative phenotype, abrogating YukE secretion (Fig. 4b). Combined, 
these results are consistent with the idea that catalytic activity of the ESX ATPase is 
required for efficient transport.
The YukBA ATPase is integral membrane protein
YukBA is predicted to be a 171 kDa integral membrane protein. We performed a 
fractionation assay to confirm that YukBA localizes to the membrane as predicted by 
sequence analyses (Fig. 1a). In this experiment, YukBA labeled with GFP was present in the 
membrane fraction and solubilized by Triton detergent but not by 1M NaCl (Fig. 5) which is 
consistent with the prediction that YukBA is an integral membrane protein. Therefore, 
similar to the mycobacterial ESX ATPases, YukBA localizes to bacterial membrane.
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Each ATPase domain of the split ESX ATPase EccCa-EccCb is required for secretion in M. 
tuberculosis
While many of the FtsK/SpoIIIE family ATPases associated with ESX secretion systems 
show a protein architecture like that of B. subtilis YukBA (multiple ATPase domains linked 
within a single polypeptide), a subset of systems, including the ESX-1 secretion system of 
M. tuberculosis, represents an alternative protein architecture where the open reading frame 
encoding the ATPase has been split into two genes. It is unclear how this varied protein 
architecture may affect the enzymatic requirements for such systems. To address this 
question, we used the M. tuberculosis system to understand the individual domain 
requirements of the ESX-1 ATPase EccCa and EccCb in ESX-1-mediated secretion.
Through the study of transposon mutants, M. tuberculosis eccCa and eccCb were previously 
shown to be required for ESX-1-mediated secretion of the protein substrates EsxA and EsxB 
[17, 18]. Similarly, we found that transposon insertions in eccCa and eccCb disrupted 
secretion of three ESX-1 substrates: EsxA, EsxB, and EspA (Fig. 6). These defects could be 
complemented by the episomal expression of eccCa-eccCb in the eccCa::Tn mutant and 
eccCb alone in the eccCb::Tn strain.
EccCa contains a single Walker A motif (K485), while EccCb contains two predicted 
Walker A motifs (K90 and K382) (Fig. 1). We mutated the conserved lysine of each ATPase 
domain to an alanine and then tested the ability of the mutant proteins to complement ESX-1 
secretion in the corresponding eccCa- or eccCb-null strains. In these studies, 
complementation of eccCa::Tn with the eccCaK485A mutant expressed with eccCb failed to 
restore secretion of EsxA, EsxB, and EspA (Fig. 6), though expression of the wild-type 
eccCa gene with eccCb restored secretion. Similarly, mutating the eccCb ATPase domains 
individually or in combination (eccCbK90A, eccCbK382A, or eccCbK90A,K382A) disrupted 
secretion of EsxA, EsxB, and EspA. Thus, each ATPase domain of eccCa and eccCb is 
required for ESX-1 mediated secretion.
Some EccCa and EccCb ATPase mutants are dominant negative on ESX-1-mediated 
secretion
We next asked whether the expression of the Walker A mutants exerted a dominant negative 
phenotype on ESX-1-mediated secretion when expressed in a wild-type background. Ectopic 
expression of each individual domain mutant (EccCaK485A, EccCbK90A, or EccCbK382A) 
blocked secretion of all of the ESX-1 substrates in a dominant negative fashion (Fig. 7). The 
inhibition of secretion was not simply due to overexpression of EccCa or EccCb, which 
could in theory dilute away required interacting proteins, as overexpression of wild-type 
copies of these proteins did not affect ESX-1-mediated secretion. The dominant negative 
phenotype displayed by the three single EccCa-EccCb ATPase mutants suggests that these 
mutant proteins enter into secretory complexes and render the complex nonfunctional.
In contrast, ectopic expression of the double mutant protein EccCbK90A,K382A did not have a 
significant dominant negative effect on ESX-1-mediated secretion (Fig. 7). While the level 
of secretion in this strain was slightly reduced as compared to wild-type, the level of 
secretion was significantly greater than was seen with the expression of any individual 
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EccCa or EccCb ATPase mutant. The lack of a dominant negative effect did not reflect a 
lower expression level of the EccCbK90A,K382A protein as the EccCbK90A,K382A mutant 
protein was present at roughly the same abundance as the EccCbK382A protein, which had a 
dominant negative effect on secretion. These results suggest that EccCb residues K90 and 
K382 might be required for EccCb to form stable protein complexes.
Discussion
To date ESX ATPases are the only absolutely conserved components of the ESX secretory 
apparatus that are present in both firmicute-like and mycobacterial subtypes of these 
secretion systems [10]. These ATPases are required for substrate translocation in all tested 
ESX secretion systems [17, 19-22]. However, prior to this work, it was unknown whether 
nucleotide binding and hydrolysis within the three predicted ESX ATPase domains are 
required for substrate translocation. Additionally, it was unclear whether the domain 
requirements were the same in biological systems representing the two possible protein 
architectures –linked or split ATPase domains. Through mutagenic analysis of the ESX 
ATPases from two different secretion systems we established that ATP hydrolysis in only 
one of the ATPases is required for secretion. Nucleotide binding within the second and third 
domains in the linked ATPase is dispensable for substrate translocation. In contrast, the split 
ESX ATPases of mycobacterial ESX-1 system seem to rely on the nucleotide binding for 
assembly.
Protein translocation across cellular membranes requires energy that is usually supplied by 
the proton motive force and/or nucleotide triphosphate hydrolysis by ATPases and GTPases. 
For most of the known translocation pathways there is one or more associated secretory 
ATPase that, apart from energizing the protein passage through membrane per se, is also 
involved in substrate recognition, unfolding, and assembly of the secretion machinery itself. 
For example, in the Type IV secretion systems there are three associated ATPases – VirD4, 
VirB4, and VirB11. All three ATPases are implicated in powering substrate translocation by 
ATP hydrolysis while specializing differently in substrate binding and pilus biogenesis [32]. 
Multidomain ATPases of the ESX secretion systems were earlier hypothesized to fuel 
substrate translocation based on their absolute necessity for secretion [17, 19]. We tested this 
hypothesis by creating Walker B mutants of the separate ATPase domains. Our results 
clearly show that ATP hydrolysis is indeed required for ESX secretion. Moreover, it seems 
that catalytic activity of only the most N-terminal ATPase domain is essential for the 
secretory function.
Despite their common hexameric form, but consistent with their diversity of functions, there 
is striking variation in the patterns of ATP utilization and oligomerization within P-loop 
ATPases. The composition of a hexameric machine can either be homogenous, formed by 
six identical protein subunits, or heterogenous, where nonidentical proteins come together to 
form a hexamer. In homohexameric ATPases, nucleotide binding results in conformational 
changes in subunits that in turn determine the hydrolysis mechanism (for example, see [33, 
34]). Several mechanisms have been proposed for the homohexameric ATPases in which all 
subunits become specialized due to allosteric effects and asymmetry (i.e. [35-38]). 
Heterohexameric ATPases represent a more extreme form of subunit specialization, where 
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active sites within a complex can be differentially required for enzyme function, serving 
active, regulatory, or structural roles. Two striking examples of heterohexameric ATPases 
are the heavy chain of the dynein motor protein and the minichromosome maintenance 
(MCM) complex. Dyneins are large microtubule-walking motors that contain six AAA+ 
ATPase domains concatenated within a single polypeptide. Of these six domains, four 
contain intact active sites that are able to bind and hydrolyze ATP while the other two 
domains have lost the conserved Walker A motif and are believed to play structural roles 
[39, 40]. These six ATPase domains with distinct functions come together to form an 
asymmetric ring-shaped oligomer [39, 41]. The MCM complex is a replicative helicase 
made up of six different proteins, Mcm2 through Mcm7 [42]. These six proteins, each 
containing a Walker A ATP binding motif, oligomerize to form a hexameric ring-shaped 
complex [43]. The six individual subunits can be divided into two functional subgroups 
where three subunits are responsible for ATP hydrolysis, while three subunits serve a 
regulatory function [44]. The unique linked protein domain structure of ESX ATPases and 
the demonstrated differences in functional requirement for each domain is most reminiscent 
of such heterohexameric ATPases. Based on our results, ESX ATPases represent a new 
striking case of domain specialization within the heteromultimeric ATPases in which one 
third of the ATPase fold is hydrolyzing ATP.
Whereas the enzymatic activity of the second two domains of the YukBA ATPase is not 
required for substrate translocation, we hypothesize that they may interact with the substrate 
as was shown for the corresponding mycobacterial domains [17, 23, 45]. It is also possible 
that these domains play a structural role in the assembly of the secretion apparatus.
Covalently linked multidomain ATPases are also known to form different assemblies. As 
described above, the dynein hexamer exists as a single layered asymmetric ring. In contrast, 
the two covalently linked ATPase domains of p97, NSF, and ClpB oligomerize into a two-
tiered structure of stacked hexameric rings [46-50]. In such two-layered barrels one of the 
homohexamers is responsible for the ATP hydrolysis while the second homohexamer is only 
capable of nucleotide binding [51-53]. By expressing mutant versions of the ESX ATPases 
in the presence of the wild-type protein we observed that the mutant forms of the ATPases 
interfere with the functionality of the wild-type ATPases (Fig. 3a-b, 4b). Such interference 
as well as the dominant negative phenotypes of some substitutions is indicative of protein 
oligomerization. Moreover, these data are consistent with the expectation that FtsK-like 
ATPases tend to hexamerize to perform their functions and therefore it is likely that the 
YukBA ATPase oligomerizes. Mycobacterial EccCa and EccCb ATPases have previously 
been shown to interact [23] Interestingly, there are two possible ways to assemble the three 
ATPase domains into hexameric ring structures. One assembly implies formation of a dimer 
of trimers resulting in a single-layered ring, while the other assembly results in a three-
layered barrel consisting of three homohexamers stacked on top of each other.
There is no known example of the assemblies of either sort. Data from S. aureus ESX 
ATPase EssC may favor the three-layered assembly as a functional unit of the ESX 
ATPases. EssC contains three linked ATPase domains and deletion of the second and third 
domains revealed that the last two domains are dispensable for a substrate secretion 
suggesting that the first ATPase domain might be capable of independent assembly [19]. 
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Future studies will be necessary to determine which ESX ATPase oligomer represents a 
functional unit. The structure of the complex is of particular interest because the ESX 
systems are shown to translocate dimeric substrates and accommodate substrates of different 
sizes [24, 54, 55].
To date only one substrate has been identified for the B. subtilis yuk system, YukE [22], 
while the ESX-1 system has multiple protein substrates. For the mycobacterial ESX-1 
ATPases it was shown that the EsxB substrate bound only to EccCb but not to EccCa under 
tested conditions [23] but the effect of the nucleotide interaction on secretion was not tested. 
Our analyses of the mycobacterial ESX-1 ATPases show that the EccCa and EccCb have the 
same specialized requirements for secretion of all three tested substrates – EsxA, EsxB, and 
EspA (Fig. 6-7). Consistent with the recent identification of widespread recognition motifs 
across ESX substrates [24, 54, 56], we conclude that the energy and ligand binding 
requirements are generalizable for different substrates of the mycobacterial ESX secretion 
system.
In our comparison of the linked and split ESX ATPases we found a striking difference in the 
nucleotide binding requirements for secretion. While the nucleotide interaction in the second 
and third domains of the linked YukBA ATPase is not required for substrate secretion, 
nucleotide binding to both of the EccCb ATPase domains is essential for secretory function. 
It is well documented that nucleotide interactions are required for the assembly of many 
multimeric ATPase motors. Therefore, we hypothesize that EccCa and EccCb assembly may 
also be regulated by the nucleotide interaction. Such a hypothesis may explain the result that 
the double Walker A mutant of EccCb does not exhibit a negative dominant phenotype 
while the single Walker A mutants do disrupt the function of the wild-type protein (Fig. 7). 
It is also interesting to consider that in the five ESX loci present in M. tuberculosis only two 
have split FtsK-like ATPases, the ESX-1 ATPases considered here, and the ESX-5 ATPases. 
Bioinformatics analyses of the mycobacterial genomes indicate that the ESX-4 locus is 
likely ancestral and it contains a linked EccC4 ATPase [16]. Thus it is tempting to propose 
that the splitting of the multidomain ATPases might have created an additional regulated 
assembly step that allows mycobacterial species to tune specificity and regulation of 
secreting the multitude of ESX-dependent substrates.
Materials and Methods
Strain construction
All M. tuberculosis strains were derived from the wild-type strain H37Rv. All B. subtilis 
strains were derived from the prototrophic strain PY79 [57]. General methods for molecular 
cloning and strain construction of B. subtilis strains were performed according to published 
protocols [58]. Chromosomal DNA isolated from M. tuberculosis H37Rv or B. subtilis 
PY79 was used as a template for all PCR amplification. Introduction of DNA into B. subtilis 
PY79 derivatives was conducted by transformation [59]. To generate M. tuberculosis 
complementing constructs, the genomic region encoding eccCa, eccCb, or eccCa-eccCb in 
tandem (including the native intergenic region), was amplified from H37Rv genomic DNA. 
Forward primers added a ribosomal binding site (GAAGGAGATATACAT) upstream of 
each start codon, and the reverse oligo of eccCb added a C-terminal Flag-tag (protein 
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sequence: DYKDDDDK). A second round of PCR added att sites for Gateway 
recombination of the product and the PCR products were recombined into a Gateway donor 
vector (pDONR, Invitrogen, Carlsbad, CA) and transferred to an episomal expression vector 
(pTETSG), which allows for regulated gene expression under the control of a tetracycline 
inducible mycobacterial promoter [60]. The resulting pTETSG constructs or an empty 
vector were transformed into wild-type H37Rv, eccCa::Tn, and eccCb::Tn strains. These 
strains were maintained under selection with 50 μg/ml Hygromycin (Roche, Mannheim, 
Germany) to prevent plasmid loss. Site directed mutagenesis of eccCa and eccCb expression 
vectors was performed to construct each Walker A mutant. The bacterial strains and 
plasmids used in this study are listed in Tables 1-4. All constructs were confirmed by 
sequencing.
Media and growth conditions
For general propagation, M. tuberculosis strains were maintained at 37°C in Middlebrook 
7H9 broth medium supplemented with 10% oleic acid-albumin-dextrose-catalase (OADC, 
Difco), 0.2% glycerol, and 0.05% Tween 80 or Middlebrook 7H10 agar containing 10% 
OADC, 0.5% glycerol, and 0.05% Tween 80. When appropriate, 50 μg mL−1 hygromycin 
was included in the growth medium. Where indicated in methods below, strains were 
cultured in Sauton’s broth medium supplemented with 0.05% Tween 80 instead of 7H9 
medium because the large quantity of albumin in 7H9 medium confounded analysis of 
secreted bacterial proteins.
B. subtilis strains were maintained at 37°C in lysogeny broth (LB) medium (10 g L−1 
tryptone, 5 g L−1 yeast extract, 5 g L−1 NaCl) or on LB plates containing 1.5% Bacto agar. 
When appropriate, antibiotics were included in the growth medium as follows: 100 μg mL−1 
spectinomycin, 5 μg mL−1 chloramphenicol, 5 μg mL−1 kanamycin, and 1 μg mL−1 
erythromycin plus 25 μg mL−1 lincomycin (mls).
Preparation of cell lysates and culture filtrates
For analysis of protein expression and secretion by M. tuberculosis, bacterial cultures grown 
to mid-log phase were normalized to an OD600 of 0.3 in fresh 7H9 medium containing 100 
ng mL−1 anhydrotetracycline (AT, Spectrum Chemicals), when appropriate, to induce 
protein expression. Cultures were grown overnight at 37°C to allow 24 hours for the 
induction of gene expression of the complementing construct prior to beginning culture 
supernatant collections. After 24 hours, cultures were pelleted, washed, resuspended in 
Sauton’s medium supplemented with 0.05% Tween 80 and AT and grown for 48 hours at 
37°C. Cell pellets were collected by centrifugation, resuspended in protein extraction buffer 
(50 mM Trism·HCL pH 7.5, 5 mM EDTA, protease inhibitor cocktail (Complete Mini, 
EDTA-free tablets, Roche)) and disrupted by bead beating. SDS sample buffer (Novex 2x 
Tricine SDS sample buffer, Invitrogen) was added and samples were heated at 95°C for 20 
minutes before removal from the biosafety level 3 facility. Protease inhibitor cocktail was 
added to the culture supernatants, which were then sterilized by double filtration through 0.2 
μM filters. The culture supernatants were concentrated by precipitation with 10% 
trichloroacetic acid (TCA), resuspended in SDS sample buffer and heated to 95°C for 20 
minutes.
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For analysis of protein expression and secretion by B. subtilis strains, mid-log bacterial 
cultures were started from a single colony, back diluted and normalized to an OD600 of 0.02 
in LB medium, and grown 2 hours at 37°C, at which time 100 μM IPTG (isopropyl-β-D-
thiogalactopyranoside) was added to induce protein expression; cultures were grown an 
additional 2 hours. Cell pellets were collected by centrifugation, resuspended in lysis buffer 
(20 mM Tris·HCl pH 7.5, 10 mM EDTA, 1 mM PMSF, 10 μg mL−1 DNase I, 100 μg mL−1 
RNaseA, 1 mg mL−1 lysozyme) and incubated at 37°C for 10 minutes. SDS sample buffer 
(Novex 2x Tricine SDS sample buffer, Invitrogen) was added and samples were heated to 
95°C for 15 minutes. Culture supernatants were filtered though a 0.2 μM filter to remove 
unlysed cells. Following the addition of a protease inhibitor cocktail (Complete Mini, 
EDTA-free tablets, Roche), the supernatants were concentrated by precipitation with 10% 
TCA, resuspended in SDS sample buffer and heated to 95°C for 15 minutes.
SDS-PAGE and immunoblot analysis
Prior to analysis, samples were reduced with 100 mM dithiothreitol (DTT) for 1 hour at 
37°C. Proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and 
transferred to a nitrocellulose membrane (Bio-Rad) for immunoblot analysis. Membranes 
were probed with anti-EsxA (ESAT-6, 1:2,000, ab26246, Abcam), anti-EsxB (CFP-10, 
1:1,000, ab45074, Abcam), anti-EspA (1:2,000, [61]), anti-Flag (1:5,000, F7425, Sigma), 
anti-YukE (polyclonal, 1:1,000, [22]) and anti-Myc (1:3,000, ab9106, Abcam) antibodies. 
Peroxidase-conjugated goat anti-rabbit (1:3,000, ab6721, Abcam) and goat anti-mouse 
(1:10,000, 32430, Thermo Scientific) secondary antibodies were detected by 
chemiluminescence using SuperSignal West Femto (Thermo Scientific). Antibodies to the 
cytosolic E. coli protein RNAP (1:1,000, WP023, Neoclone) or the cytosolic B. subtilis 
protein SigmaA (1:1,000,000 [62]) were used to ensure equal protein loading and as a lysis 
control for M. tuberculosis and B. subtilis immunoblots, respectively. Equal loading of 
culture supernatants was confirmed by visualizing the total protein loaded by Coomassie 
staining. Blots were imaged and densitometric quantitation of YukE, EsxA, EsxB, and EspA 
secretion was performed using a FluorChem FC2 gel documentation system (Alpha 
Innotech) and provided software.
Fractionation of B. subtilis lysates
YukBA labeled with GFP was ectopically expressed in B. subtilis upon IPTG induction. 
Whole cell lysates were prepared from cells grown in LB medium and harvested during 
mid-exponential phase. Soluble (S3) and insoluble (P3) protein fractions were separated by 
centrifugation at 3,000 × g. The S3 fraction was further separated by centrifugation at 
100,000 × g to collect the soluble (S100) and insoluble (P100) fractions. The P100 fraction 
was divided into three equal volumes and incubated with either buffer, 1M NaCl, or 10% 
Triton detergent and then spun again at 100,000 × g to collect the soluble (S100) and 
insoluble (P100) fractions. The samples were analyzed by SDS-PAGE under reducing 
conditions and Western blot with anti-GFP antibodies.
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• Three ATPase domains in the ESX ATPases contribute differently to secretion
• ATP hydrolysis by the first ATPase domain is required for ESX secretion
• Linked and split ESX ATPases differ in their requirement for nucleotide binding
Abbreviations
ESX early secretory antigen target 6 kDa (ESAT-6) secretion
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Figure 1. ATPases of the ESX secretion systems
(a) Protein domain structure of the ESX-1-encoded ATPases EccCa-EccCb of M. 
tuberculosis and the yuk-encoded ATPase YukBA of B. subtilis. Predicted FtsK-like ATPase 
domains are indicated as boxes of different shades of grey. The positions of Walker A and B 
motifs of each ATPase domain are indicated. (b) Excerpts of the alignment of all six ATPase 
domains of the YukBA, EccCa, and EccCa ATPases showing conserved Walker motifs. The 
additional “DE” site that was tested for the second YukBA domain is marked with double 
asterisk (**) above the alignment.
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Figure 2. Walker A motif of the first ATPase domain of YukBA is required for substrate 
secretion
(a) and (b) Immunoblot analysis of cell pellet (P) and culture supernatant (S) of indicated 
strains grown in LB medium. Each yukBA Walker A motif mutant was C-terminally myc-
tagged, fused to an IPTG- inducible promoter (Phyperspank), and inserted in single copy at a 
nonessential locus in the chromosome of the ΔyukBA strain. A dash (−) indicates a strain 
lacking an integrated copy of yukBA. Strains expressing yukBA K to A (a) and K to T (b) 
Walker A motif mutants were assayed for YukE secretion. Reduced P and S samples were 
separated on an SDS-PAGE gel and analyzed by immunoblot with YukE-specific antibodies 
(antibody specificity is demonstrated by the ΔyukE strain). An α-Myc antibody was used to 
verify expression of the YukBA complementing constructs; an antibody to SigmaA was 
used as a lysis and loading control.
Ramsdell et al. Page 18













Figure 3. YukBA Walker A motif mutants might interfere with the function of the wild-type 
YukBA
(a) and (b) Immunoblot analysis of cell pellet (P) and culture supernatant (S) of indicated 
strains grown in LB medium. Each yukBA ATPase mutant gene was C-terminally myc-
tagged, fused to an IPTG- inducible promoter (Phyperspank), and inserted in single copy at a 
nonessential locus in the chromosome of an otherwise wild-type strain. A dash (−) indicates 
a strain lacking an integrated copy of yukBA. Strains expressing yukBA K to A (a) and K to 
T (b) ATPase mutants were assayed for YukE secretion. Reduced P and S samples were 
separated on an SDS-PAGE gel and analyzed by immunoblot with YukE-specific antibodies 
(antibody specificity is demonstrated by the ΔyukE strain). An α-Myc antibody was used to 
verify expression of the YukBA complementing constructs, and an antibody to SigmaA was 
used as a lysis and loading control.
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Figure 4. ATP hydrolysis in the first ATPase domain is required for secretion
(a) Immunoblot analysis of cell pellet (P) and culture supernatant (S) of indicated strains 
grown in LB medium. Each yukBA ATPase mutant gene was C-terminally myc-tagged, 
fused to an IPTG- inducible promoter (Phyperspank), and inserted in single copy at a 
nonessential locus in the chromosome of an otherwise wild-type strain. A dash (-) indicates 
a strain lacking an integrated copy of yukBA. Strains expressing Walker B YukBA mutants 
were assayed for YukE secretion. Reduced P and S samples were separated on an SDS-
PAGE gel and analyzed by immunoblot with YukE-specific antibodies. An α-Myc antibody 
was used to verify expression of the YukBA complementing constructs, and an antibody to 
SigmaA was used as a lysis and loading control. (b) Same as in (a) Walker B mutants of 
YukBA were expressed in wild-type yuk operon background. These strains were used to test 
the effects of the presence of two different YukBA copies on YukE secretion.
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Figure 5. YukBA is integral membrane protein
Biochemical fractionation of YukBA-GFP was conducted to assess whether YukBA-GFP 
was a membrane-associated or integral membrane protein. YukBA-GFP has a predicted 
molecular weight of 199 kDa consistent with the species detected with GFP-specific 
antibodies. Soluble (S3) and insoluble (P3) protein fractions separated by centrifugation at 
3,000 × g; soluble (S100) and insoluble (P100) fractions that were separated from the S3 
fraction by centrifugation at 100,000 × g. The P100 fraction was further separated by 
incubation with either buffer, 1M NaCl, or 10% Triton detergent with subsequent spin at 
100,000 × g to collect the soluble (S100) and insoluble (P100) fractions. YukBA elutes from 
the membrane P100 fraction only upon membrane solubilization with Triton that is 
indicative of an integral membrane protein.
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Figure 6. Each ATPase domain of the split EccCa-EccCb ATPase is required for secretion
Immunolot analysis of cell pellet (P) and culture supernatant (S) of the indicated strains 
grown in Sauton’s medium. Each eccCa or eccCb Walker A motif mutant construct was 
episomally expressed in the corresponding eccCa::Tn or eccCb::Tn strain. A dash (-) 
indicates expression of an empty vector control. In each complementing construct, eccCb 
was C-terminally flag-tagged. Samples were separated by SDS-PAGE under reducing 
conditions and analyzed for ESX-1 secretion using antibodies specific to the ESX-1 
substrates EsxA, EsxB, and EspA. An ESX-1 deletion mutant, ΔRD1 [63], was used as a 
negative control; an antibody to E. coli RNAP was used as a lysis and loading control. Data 
are representative of at least three independent experiments.
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Figure 7. Some mutations in the ATPase domains of EccCa-EccCb exhibit a dominant negative 
effect on secretion
Immunoblot analysis of cell pellet (P) and culture supernatant (S) of the indicated strains 
grown in Sauton’s medium. Each eccCa or eccCb Walker A motif mutant construct was 
episomally expressed in wild-type H37Rv. A dash (−) indicates expression of an empty 
vector control. In each complementing construct, eccCb was C-terminally flag-tagged. 
Samples were separated by SDS-PAGE under reducing conditions and analyzed for ESX-1 
secretion using antibodies specific to the ESX-1 substrates EsxA, EsxB, and EspA. An 
ESX-1 deletion mutant, ΔRD1 [63], was used as a negative control; an antibody to E. coli 
RNAP was used as a lysis and loading control. Data are representative of at least three 
independent experiments.
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Table 1
B. subtilis strains used in this study
Strain Genotype Source,
Reference
PY79 Prototrophic domesticated laboratory strain [56]
bLH014 yukE::cat This work
bLH015 yukE::erm-Pyuk [22]
bLH110 yukBA::erm-Pyuk [22]
bLH266 amyE::Phyperspank-yukBA-myc (spec) This work
bLH267 amyE::Phyperspank-yukBAK688A-myc (spec) This work
bLH268 amyE::Phyperspank-yukBAK1016A-myc (spec) This work
bLH269 amyE::Phyperspank-yukBAK1299A-myc (spec) This work
bLH318 amyE::Phyperspank-yukBAK688A,K1016A-myc (spec) This work
bLH319 amyE::Phyperspank-yukBAK688A,K1299A-myc (spec) This work
bLH320 amyE::Phyperspank-yukBAK1016A,K1299A-myc (spec) This work
bLH321 amyE::Phyperspank-yukBAK688A,K1016A,K1299A-myc (spec) This work
bLH397 amyE::Phyperspank-yukBAK688T-myc (spec) This work
bLH398 amyE::Phyperspank-yukBAK1016Tmyc (spec) This work
bLH399 amyE::Phyperspank-yukBAK1299T-myc (spec) This work
bLH400 amyE::Phyperspank-yukBAK688T,K1016T-myc (spec) This work
bLH401 amyE::Phyperspank-yukBAK1016T,K1299T-myc (spec) This work
bLH402 amyE::Phyperspank-yukBAK688T,K1299T-myc (spec) This work
bLH403 amyE::Phyperspank-yukBAK688T,K1016T,K1299T-myc (spec) This work
bLH404 yukBA::erm-Pyuk; amyE::Phyperspank-yukBA-myc (spec) [22]
bLH405 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK688A-myc (spec) This work
bLH406 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK1016A-myc (spec) This work
bLH407 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK1299A-myc (spec) This work
bLH408 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK688A,K1016A-myc (spec) This work
bLH409 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK1016A,K1299A-myc (spec) This work
bLH410 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK688A,K1299A-myc (spec) This work
bLH411 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK688A,K1016A,K1299A-myc (spec) This work
bLH412 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK688T-myc (spec) This work
bLH413 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK1016Tmyc (spec) This work
bLH414 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK1299Tmyc (spec) This work
bLH415 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK688T,K1016T-myc (spec) This work
bLH416 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK1016T,K1299T-myc (spec) This work
bLH417 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK688T,K1299T-myc (spec) This work
bLH418 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAK688T,K1016T,K1299T-myc (spec) This work
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Strain Genotype Source,
Reference
bTS254 amyE::Phyperspank-yukBAD794A-myc (spec) This work
bTS255 amyE::Phyperspank-yukBAD1115A-myc (spec) This work
bTS256 amyE::Phyperspank-yukBAD1121A-myc (spec) This work
bTS257 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAD794A-myc (spec) This work
bTS258 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAD1115A-myc (spec) This work
bTS259 yukBA::erm-Pyuk; amyE::Phyperspank-yukBAD1121A-myc (spec) This work
bLH001 Ω yukBA-gfp (spec) This work
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Table 2
M. tuberculosis strains used in this study
Strain Genotype Source, Reference




H37RV-1 pTETSG (empty) This work
eccCa::Tn-1 eccCa::Tn; pTETSG (empty) This work
eccCb::Tn-1 eccCb::Tn; pTETSG (empty) This work
H37Rv-57 pTETSG-eccCbK90A-flag This work
eccCb::Tn-57 eccCb::Tn; pTETSG-eccCbK90A-flag This work
H37Rv-58 pTETSG-eccCbK382A-flag This work
eccCb::Tn-58 eccCb::Tn; pTETSG-eccCbK382A-flag This work
H37Rv-59 pTETSG-eccCbK90A, K382A-flag This work
eccCb::Tn-59 eccCb::Tn; pTETSG- eccCbK90A, K382A-flag This work
H37RV-61 pTETSG-eccCb-flag This work
eccCb::Tn-61 eccCb::Tn; pTETSG-eccCb-flag This work
H37Rv-105 pTETSG-eccCa-eccCb-flag This work
eccCa::Tn-105 eccCa::Tn; pTETSG-eccCa-eccCb-flag This work
H37Rv-106 pTETSG-eccCaK485A-eccCb-flag This work
eccCa::Tn-106 eccCa::Tn; pTETSG-eccCaK485A-eccCb-flag This work
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Table 3
B. subtilis plasmids used in this study
Plasmid Description Source
pLH016 yukEr::cat This work
pLH018 yukE::erm-Pyuk This work
pLH026 yukBA::erm-Pyuk This work
pLH042 amyE::Phyperspank-yukBA-myc (spec) This work
pLH054 His6-SUMO-YukE This work
pTLR235 amyE::Phyperspank-yukBAK688A-myc (spec) This work
pTLR236 amyE::Phyperspank-yukBAK1016A-myc (spec) This work
pTLR237 amyE::Phyperspank-yukBAK1299A-myc (spec) This work
pTLR245 amyE::Phyperspank-yukBAK688A,K1016A-myc (spec) This work
pTLR246 amyE::Phyperspank-yukBAK1016A,K1299A-myc (spec) This work
pTLR247 amyE::Phyperspank-yukBAK688A,K1299A-myc (spec) This work
pTLR248 amyE::Phyperspank-yukBAK688A,K1016A,K1299A-myc (spec) This work
pTLR252 amyE::Phyperspank-yukBAK688T-myc (spec) This work
pTLR253 amyE::Phyperspank-yukBAK1016T-myc (spec) This work
pTLR254 amyE::Phyperspank-yukBAK1299T-myc (spec) This work
pTLR255 amyE::Phyperspank-yukBAK688T,K1016T-myc (spec) This work
pTLR256 amyE::Phyperspank-yukBAK1016T,K1299T-myc (spec) This work
pTLR257 amyE::Phyperspank-yukBAK688T,K1299T-myc (spec) This work
pTLR258 amyE::Phyperspank-yukBAK688T,K1016T,K1299T-myc (spec) This work
pTS237 amyE::Phyperspank-yukBAD794A-myc (spec) This work
pTS238 amyE::Phyperspank-yukBAD115A-myc (spec) This work
pTS239 amyE::Phyperspank-yukBAD1121A-myc (spec) This work
pLH001 Ω yukBA-gfp (spec) This work
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Table 4
M. tuberculosis plasmids used in this study
Plasmid Description Source,
Reference
pTETSG Episomal expression vector constructed to express genes under the
control of a tetracycline inducible mycobacterial promoter
[62]
pTLR089 pTETSG-eccCbK90A-flag This work
pTLR090 pTETSG-eccCbK382A-flag This work
pTLR091 pTETSG-eccCbK90A,K382A-flag This work
pTLR171 pTETSG-eccCa-flag This work
pTLR172 pTETSG-eccCb-flag This work
pTLR184 pTETSG-eccCa-eccCb-flag This work
pTLR250 pTETSG-eccCaK485A-eccCb-flag This work
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